drugset / Trial / NCT01938716
Gemcitabine Pharmacokinetics After Preoperative Chemoradiation Therapy
NaSingle-groupOpen-labelBasic science
Summary
The goal of this clinical research study is to learn if gemcitabine given during surgery can enter pancreas cancer cells in patients who have already received chemotherapy and radiation. Gemcitabine is a drug used to treat pancreatic cancer. However, it has not previously been studied if gemcitabine can enter pancreatic cancer cells. Gemcitabine is designed to block the growth of cancer cells, which may cause cancer cells to die.
Timeline
- Start
- 2012-03
- Primary completion
- 2019-06-03
- Completion
- 2019-06-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Gemcitabine | Small molecule | 500 mg/m2 | Intravenous |
| Subject | Gemcitabine | Small molecule | 750 mg/m2 | Intravenous |